Vanda Pharmaceuticals

(NASDAQ) VNDA

Current Price$7.54

Market Cap$413.76M

Since IPO (2006)-28%

5 Year-58%

1 Year+58%

1 Month-1%

Vanda Pharmaceuticals Financials at a Glance

Market Cap

$413.76M

Revenue (TTM)

$216.10M

Net Income (TTM)

$220.47M

EPS (TTM)

$-3.74

P/E Ratio

-1.87

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$7.54

Volume

34,921

Open

$7.29

Price

$7.54

Volume

34,921

Open

$7.29

Previous Close

$7.00

Daily Range

$7.29 - $7.54

52-Week Range

$3.81 - $9.94

Dividend

$0.00

Beta (Volatility)

0.74 (Low)

Price

$7.54

Volume

34,921

Open

$7.29

Previous Close

$7.00

Daily Range

$7.29 - $7.54

52-Week Range

$3.81 - $9.94

VNDA News

1 Pharma Stock to Avoid at All Costs

Zhiyuan SunMay 15, 2020

Page 1

VNDA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vanda Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

533

CEO

Mihael Hristos Polymeropoulos, MD

Website

www.vandapharma.com

Headquarters

Washington, DC 20037, US

VNDA Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

-72%

Net Income Margin

-1%

Return on Equity

-51%

Return on Capital

-45%

Return on Assets

-45%

Earnings Yield

-53.48%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$413.76M

Shares Outstanding

59.11M

Volume

34.92K

Avg. Volume

2.49M

Financials (TTM)

Gross Profit

$203.06M

Operating Income

$151.17M

EBITDA

$139.25M

Operating Cash Flow

$109.44M

Capital Expenditure

$998.00K

Free Cash Flow

$110.44M

Cash & ST Invst.

$263.85M

Total Debt

$12.62M

Vanda Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$57.22M

+7.6%

Gross Profit

$53.38M

+5.5%

Gross Margin

93.30%

N/A

Market Cap

$413.76M

N/A

Market Cap/Employee

$1.12M

N/A

Employees

368

N/A

Net Income

$141.19M

-2774.3%

EBITDA

$34.49M

-315.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$251.22M

-30.7%

Accounts Receivable

$54.58M

+15.9%

Inventory

$1.85M

+7.3%

Long Term Debt

$7.07M

-12.6%

Short Term Debt

$5.55M

+30.1%

Return on Assets

-45.09%

N/A

Return on Invested Capital

-45.00%

N/A

Free Cash Flow

$29.52M

-1353.4%

Operating Cash Flow

$29.42M

-1519.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AVIRAtea Pharmaceuticals, Inc.

AVIRAtea Pharmaceuticals, Inc.$5.76+3.23%

ALLOAllogene Therapeutics, Inc.

ALLOAllogene Therapeutics, Inc.$2.23+3.95%

ARCTArcturus Therapeutics Holdings Inc.

ARCTArcturus Therapeutics Holdings Inc.$8.68+0.52%

SGMTSagimet Biosciences Inc.

SGMTSagimet Biosciences Inc.$7.55-0.77%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$3.87+2.93%

ACHVAchieve Life Sciences, Inc.

ACHVAchieve Life Sciences, Inc.$4.37-0.23%

TRDAEntrada Therapeutics, Inc.

TRDAEntrada Therapeutics, Inc.$15.82+9.10%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.48+2.67%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.21+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.74+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.65+0.03%

PNSkycorp Solar Group

PNSkycorp Solar Group$5.53+0.93%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.09-0.09%

ADTADT

ADTADT$7.08-0.06%

Questions About VNDA

What is the current price of Vanda Pharmaceuticals?

Vanda Pharmaceuticals is trading at $7.54 per share.

What is the 52-week range for Vanda Pharmaceuticals?

Over the past 52 weeks, Vanda Pharmaceuticals has traded between $3.81 and $9.94.

How much debt does Vanda Pharmaceuticals have?

As of the most recent reporting period, Vanda Pharmaceuticals reported total debt of $12.62M.

How much cash does Vanda Pharmaceuticals have on hand?

Vanda Pharmaceuticals reported $84.95M in cash and cash equivalents in its most recent financial results.

What is Vanda Pharmaceuticals’s dividend yield?

Vanda Pharmaceuticals does not currently have a dividend yield.

Vanda Pharmaceuticals

Vanda Pharmaceuticals Financials at a Glance

VNDA News

Should You Invest in This Under-the-Radar Weight Loss Stock?

Vanda (VNDA) Q2 Revenue Rises 4%

Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today

Why Vanda Pharmaceuticals Stock Is Skyrocketing Today

Why Shares of Vanda Pharmaceuticals Are Dropping on Tuesday

Why Vanda Pharmaceuticals Stock Crawled Higher Today

Here's Why Vanda Pharmaceuticals Jumped Higher Today

1 Pharma Stock to Avoid at All Costs

VNDA: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Vanda Pharmaceuticals

VNDA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Vanda Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VNDA

What is the current price of Vanda Pharmaceuticals?

What is the 52-week range for Vanda Pharmaceuticals?

How much debt does Vanda Pharmaceuticals have?

How much cash does Vanda Pharmaceuticals have on hand?

What is Vanda Pharmaceuticals’s dividend yield?

Premium Investing Services